Showing results (1021-1030 of 4,508) with videos related to
Sort By:
Pageof 451
Springerplus|February 13, 2015
Interdisciplinary communication of infectious disease research - translating complex epidemiological findings into understandable messages for village chicken farmers in MyanmarJoerg Henning, Than Hla, Joanne MeersSpringerplus|February 13, 2015
Overexpression of MRP4 (ABCC4) and MRP5 (ABCC5) confer resistance to the nucleoside analogs cytarabine and troxacitabine, but not gemcitabineAuke D Adema, Karijn Floor, Kees Smid, et al.Springerplus|February 13, 2015
Diminished mTOR signaling: a common mode of action for endocrine longevity factorsDudley W LammingSpringerplus|February 13, 2015
Dynamics of natural populations of the dertitivorous mudsnail Potamopyrgus antipodarum (Gray) (Hydrobiidae) in two interconnected Lakes differing in trophic stateJaap Dorgelo, Harm G van der Geest, Ellard R HuntingSpringerplus|February 13, 2015
The effect size, study design, and development experience in commercially sponsored studies for new drug applications in approved drugsSatoshi Fukunaga, Makiko Kusama, Shunsuke OnoSpringerplus|February 13, 2015
Effects of pressure angle and tip relief on the life of speed increasing gearbox: a case studySankar Shanmugasundaram, Manivarma Kumaresan, Nataraj MuthusamySpringerplus|February 13, 2015
Calibration of an automated California mastitis test with focus on the device-dependent variationAnne-Christin Neitzel, Eckhard Stamer, Wolfgang Junge, et al.Springerplus|February 13, 2015
Levels of major and trace elements in fennel (Foeniculum vulgari Mill.) fruits cultivated in EthiopiaFeleke Demissie Endalamaw, Bhagwan Singh ChandravanshiSpringerplus|February 13, 2015
CyberKnife multisession stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for perioptic meningiomas: intermediate-term results and radiobiological considerationsAlfredo Conti, Antonio Pontoriero, Federica Midili, et al.Springerplus|February 13, 2015
Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulationsAnn Butler Nattinger, Liliana E Pezzin, Emily L McGinley, et al.Pageof 451